A detailed history of Orion Portfolio Solutions, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 269,665 shares of NVO stock, worth $22.9 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
269,665
Previous 273,925 1.56%
Holding current value
$22.9 Million
Previous $39.1 Million 17.88%
% of portfolio
0.34%
Previous 0.44%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$119.07 - $145.42 $507,238 - $619,489
-4,260 Reduced 1.56%
269,665 $32.1 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $3.18 Million - $3.8 Million
-25,881 Reduced 8.63%
273,925 $39.1 Million
Q1 2024

May 09, 2024

SELL
$102.11 - $135.92 $1.05 Million - $1.4 Million
-10,281 Reduced 3.32%
299,806 $38.5 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $8.35 Million - $10 Million
95,176 Added 44.29%
310,087 $32.1 Million
Q3 2023

Nov 01, 2023

BUY
$90.94 - $199.54 $10.2 Million - $22.3 Million
111,905 Added 108.64%
214,911 $19.5 Million
Q2 2023

Aug 17, 2023

BUY
$155.98 - $172.65 $685,064 - $758,278
4,392 Added 4.45%
103,006 $16.7 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $14.8 Million - $16.4 Million
95,141 Added 2739.45%
98,614 $16 Million
Q1 2023

Aug 30, 2023

SELL
$132.34 - $159.14 $2.09 Million - $2.51 Million
-15,783 Reduced 15.32%
87,223 $13.9 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $173,762 - $208,950
1,313 Added 60.79%
3,473 $552,000
Q4 2022

Feb 08, 2023

BUY
$102.55 - $135.33 $221,508 - $292,312
2,160 New
2,160 $292,000
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $989 - $1,295
-20 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $997 - $1,165
20 New
20 $1,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.